Why are many pharmaceutical companies outsourcing their chromatographic needs to contract research organizations?
Janet Kesley spoke with Richard LeLacheur, vice president of Taylor Technology about why many pharmaceutical companies are outsourcing their chromatographic needs to contract research organizations (CROs).
Characterization of Product Related Variants in Therapeutic Monoclonal Antibodies
July 16th 2024Navin Rauniyar and Xuemei Han of Tanvex Biopharma USA recently discussed how identifying product-related variants through characterization enables the recognition of impurities that compromise the quality and safety of drugs.